Skip to content

RxSight, Inc.

RXST

CIK 0001111485 · Ophthalmic Goods · Nasdaq

  • CALHOUN VISION INC (until 2014-03-20)
← back to feed
Revenue (TTM)
$132.77M
−3.9% YoY Q1 May 2026
Net Income (TTM)
−$45.68M
−41.8% YoY Q1 May 2026
EPS Diluted (TTM)
−$1.11
−33.8% YoY Q1 May 2026
Gross Margin
76.3%
Q1 May 2026
Operating Margin
-41.2%
Q1 May 2026
Net Margin
-34.4%
Q1 May 2026
Free Cash Flow (TTM)
−$50.84M
Q1 May 2026
Cash
$17.57M
Q1 May 2026
Total Debt
$0
Q1 May 2026
Shares Outstanding
41.4M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings